Legal Disclaimer and Licensing Notice

This Legal Disclaimer and Licensing Notice (this “Notice”) applies to all works published by the Geno Project or under the trade names “Geno Project” or “GENO Research” (collectively, the “Work”), including without limitation research papers, companion and supplementary papers, articles, essays, preprints, working papers, technical notes, data tables, figures, illustrations, code, documentation, and any other written, graphical, computational, or multimedia material, whether published on this website, on third-party academic or preprint repositories, on social or professional media, in print, or in any other form or medium, and whether published at the effective date of this Notice or at any time thereafter.

© 2026 Category One Limited. All rights reserved. Category One Limited is a Business Company incorporated in the British Virgin Islands (BVI Business Company No. 2208440) and is the legal entity that owns the economic copyright in the Work and that operates under the trade names “Geno Project” and “GENO Research.” The author of the Work is Dr. Yousef Jum’a Saleh. The economic copyright is held by Category One Limited pursuant to a written assignment of rights from the author. The moral rights of the author are retained by the natural-person author and are not transferred by the assignment of economic rights, as further provided in Section 3. Inquiries directed to the author should be sent through the addresses provided in Section 18 of this Notice.

The Work is licensed under the Creative Commons Attribution–Noncommercial–No Derivatives 4.0 International License (CC BY-NC-ND 4.0). You are permitted to share the Work in any medium or format, provided that you give appropriate credit to the Geno Project, provide a link to the license, indicate if changes were made, do not use the material for commercial purposes, and do not distribute modified or derivative versions of the Work.

Full license terms are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.

Attribution. You must give appropriate credit to the Geno Project, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the Geno Project or Category One Limited endorses you or your use of the Work.

Noncommercial. You may not use the Work for commercial purposes. Commercial purposes include, without limitation, incorporation into paid products or services, use in marketing or promotional materials, sale or licensing to third parties, and use in the development of competing financial products, protocols, or platforms.

No Derivatives. You may not remix, transform, translate, adapt, or build upon the Work and distribute the modified material. Summaries, abstracts, or commentary that constitute fair use or fair dealing under applicable law are permitted, provided they include proper attribution to the Geno Project.

The author of the Work asserts moral rights of attribution and integrity under Article 6bis of the Berne Convention for the Protection of Literary and Artistic Works, to which Jordan, the United Arab Emirates, the United States, and more than 180 other nations are signatories, and under the national copyright laws of each jurisdiction in which protection is claimed. These rights include the right to be identified as the author of the Work and the right to object to any distortion, mutilation, modification, or other derogatory action in relation to the Work that would be prejudicial to the author’s honor or reputation. Moral rights are personal to the natural-person author, are inalienable, and are not waived or transferred by the assignment of economic rights to Category One Limited or by the grant of license in Section 2 above.

All intellectual property rights in the Work, including but not limited to the text, tables, figures, equations, mathematical frameworks, system architecture descriptions, economic models, and original analysis contained in the Work, are owned by Category One Limited. The Counter-Inflation Currency (CIC), the Geno token, and all associated system designs, mechanisms, methodologies, algorithms, and economic frameworks described in the Work are proprietary to Category One Limited.

No part of the Work may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, whether electronic, mechanical, photocopying, recording, or otherwise, except as expressly permitted under the license stated in Section 2, without the prior written permission of Category One Limited.

The underlying ideas, mathematical principles, and economic theories described in the Work are not themselves subject to copyright protection and may be independently developed by others. However, any reproduction, republication, or redistribution of the specific textual expression, figures, tables, equations, or presentation contained in the Work must comply with the license terms set forth in Section 2.

“Counter-Inflation Currency,” “CIC,” “Geno,” “Geno Project,” and “GENO Research” are trademarks of Category One Limited, whether registered or unregistered, and are used under common-law trademark rights as of the first publication date of this Notice. Any other trademarks or trade names referenced in the Work are the property of their respective owners. The use of any trademark in the Work does not grant any license to the trademark, and all trademark rights are expressly reserved by their respective owners.

The Work discloses portions of the CIC and Geno architectures for academic and expository purposes. Additional implementation details, operational parameters, security measures, calibration data, and mechanism specifics are held as trade secrets of Category One Limited, are deliberately not disclosed in the Work, and are not licensed by publication of the Work. The absence of any particular detail from the Work shall not be construed as an indication that such detail does not exist or is not protected, nor as a waiver of Category One Limited’s trade secret rights in any undisclosed material.

No patent rights are granted, expressly or by implication, by the publication of the Work. All patent rights that may attach to any methods, systems, mechanisms, frameworks, or algorithms described in the Work are reserved by Category One Limited to the extent such rights exist under applicable law. The publication of the Work does not constitute a dedication of any such rights to the public domain, a waiver of any such rights, or the commencement of any statutory grace period except as may be required by operation of law.

Readers and users of the Work are expressly prohibited from filing, applying for, or prosecuting any patent, utility model, or similar intellectual property registration in any jurisdiction, to the extent that such filing is based upon, derived from, or informed by any method, system, mechanism, framework, algorithm, or concept described in the Work. Any such filing shall constitute a material breach of this Notice and shall entitle Category One Limited to seek injunctive relief, damages, and invalidation of such filing on the basis of the prior art established by the Work’s publication.

The publication of the Work constitutes a defensive publication establishing prior art under the patent laws of all jurisdictions that recognize published prior art, including without limitation 35 U.S.C. § 102 (United States), Article 54 of the European Patent Convention, and equivalent provisions under the Patent Cooperation Treaty and national patent statutes. Each work published under the Geno Project establishes prior art as of its documented first-circulation date. Category One Limited maintains timestamped records of all first-circulation dates and will make such records available to any patent office, court, or tribunal in support of prior art challenges to patent applications filed by third parties that claim inventions disclosed in the Work.

Any party who accesses the Work and subsequently files a patent application claiming subject matter disclosed herein does so with constructive and actual notice that the claimed subject matter was previously disclosed and published by Category One Limited under the Geno Project.

No person or entity who accesses the Work may circumvent the restrictions of this Notice by directing, advising, financing, or assisting any third party — including without limitation any subsidiary, affiliate, agent, contractor, joint venture partner, portfolio company, or related entity — to undertake any action that the person or entity accessing the Work is itself prohibited from undertaking under this Notice. Any such circumvention shall be deemed a direct breach of this Notice by the accessing party.

All rights not expressly granted under the license in Section 2 are reserved by Category One Limited. In particular, and without limiting the generality of the foregoing reservation, Category One Limited reserves all rights to commercial use of the Work, to the preparation of derivative works, to translations into any language, to adaptations into other media, and to the inclusion of the Work or any substantial portion of it in machine learning training corpora, retrieval-augmented generation systems, large language model training datasets, vector databases, embedding models, or any other automated-processing datasets. The license in Section 2 does not grant such rights, and Category One Limited expressly declines to grant them by implication or by silence. Any party wishing to use the Work in a manner not expressly permitted by the license must obtain prior written permission from Category One Limited.

For the avoidance of doubt, no implied license is granted under any intellectual property right held by Category One Limited, whether by estoppel, exhaustion, course of dealing, or otherwise. The publication of the Work and the grant of the limited license in Section 2 shall not be construed as creating any implied license to practice, implement, deploy, or commercialize any method, system, or mechanism described in the Work.

Individual works should be cited using the following format: Saleh, Y. J. (2026). [Work Title]. GENO Research Series, [Paper Type]. Category One Limited. Retrieved from https://geno.ac.

When citing the body of work as a whole: Saleh, Y. J. (2026). The GENO Research Series. Category One Limited. Retrieved from https://geno.ac.

Each work published under the Geno Project is dated individually and asserts priority of the definitions, theorems, proofs, mechanisms, and arguments contained therein as of its first-circulation date. Subsequent revised versions of any work will be dated separately. Category One Limited maintains an internal record of first-circulation dates and cryptographic hashes for each work and will make such records available in connection with any priority dispute.

The Work is academic research. It does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security, token, financial product, investment strategy, or other financial instrument in any jurisdiction. Nothing contained in the Work should be construed as investment advice, financial advice, trading advice, legal advice, tax advice, accounting advice, or any other form of professional advice.

The information presented in the Work is for informational and academic purposes only. Any forward-looking statements, projections, economic models, or hypothetical scenarios are based on theoretical frameworks and mathematical analysis, reflect assumptions that may not hold in any particular real-world environment, and do not represent guarantees, predictions, or warranties of future performance. No regulatory authority in any jurisdiction has reviewed, approved, or endorsed the contents of the Work.

Readers should conduct their own independent research and consult qualified professional advisors licensed in their jurisdiction before making any investment, financial, legal, or tax decisions. The Work does not create any adviser-client, fiduciary, broker-dealer, or other professional relationship between Category One Limited or the Geno Project and any reader.

All data, statistics, and empirical references cited in the Work have been sourced from publicly available databases and publications, including but not limited to the International Monetary Fund (IMF), the Federal Reserve System, the Bank for International Settlements (BIS), the World Bank, CEIC Data, Trading Economics, and corporate filings with the U.S. Securities and Exchange Commission (SEC). Where third-party data is cited, such data remains the property of its respective source and is used for academic purposes consistent with fair use or fair dealing under applicable law.

While every reasonable effort has been made to ensure accuracy and currency of the data presented, Category One Limited makes no representations or warranties, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of any information contained in the Work. Economic data is subject to revision by issuing authorities. Monetary aggregates, velocity figures, and other macroeconomic indicators cited reflect the most current data available at the time of each work’s first circulation and may have been subsequently revised.

The Work is provided “as is” without warranty of any kind, whether express, implied, or statutory, including but not limited to warranties of merchantability, fitness for a particular purpose, accuracy, completeness, non-infringement, or title. Category One Limited makes no representation that the definitions, theorems, proofs, mechanisms, or arguments described in the Work are free from error, suitable for any particular application, or non-infringing of any third-party rights. Readers who rely on the Work in academic, commercial, professional, or other contexts do so at their own risk.

In no event shall Category One Limited, the Geno Project, its authors, contributors, affiliates, agents, or licensors be liable for any direct, indirect, incidental, special, consequential, punitive, or exemplary damages, including but not limited to damages for loss of profits, loss of data, loss of reputation, business interruption, or other intangible losses, arising out of or in connection with the use of, or reliance upon, any information contained in the Work, whether based on warranty, contract, tort (including negligence), or any other legal theory, and whether or not Category One Limited has been advised of the possibility of such damages.

This Notice and the license in Section 2 shall be governed by and construed in accordance with applicable international copyright law, including the Berne Convention for the Protection of Literary and Artistic Works. Category One Limited reserves the right to pursue disputes arising from unauthorized use of the Work in the courts of any jurisdiction in which infringement occurs. Under 17 U.S.C. § 504(c) of the United States Copyright Act, willful infringement of a work registered with the U.S. Copyright Office prior to infringement, or within the grace periods permitted by 17 U.S.C. § 412, may result in statutory damages of up to $150,000 per infringed work, in addition to recovery of attorney’s fees and costs. U.S. Copyright Office registration numbers for works covered by this Notice will be added as they are received.

If any provision of this Notice is held to be invalid or unenforceable in any jurisdiction, the remaining provisions shall remain in full force and effect, and the invalid or unenforceable provision shall be modified to the minimum extent necessary to render it enforceable while preserving its original intent. The invalidity or unenforceability of any provision in any jurisdiction shall not affect the validity or enforceability of that provision in any other jurisdiction.

By downloading, reading, citing, reproducing, or otherwise using the Work, you acknowledge that you have read this Notice, understand its terms, and agree to be bound by them. If you do not agree to the terms of this Notice, you must not download, read, cite, reproduce, or otherwise use the Work.

The terms of this Notice constitute a binding agreement between Category One Limited and any person or entity that accesses the Work. The act of accessing the Work — whether by downloading, reading, viewing, receiving, or otherwise obtaining or using the Work or any portion thereof — constitutes unambiguous acceptance of all terms of this Notice. This acceptance is irrevocable with respect to any access that has already occurred. The accessing party represents that it has the legal authority and capacity to enter into binding agreements and that it accepts the obligations set forth in this Notice on behalf of itself and any entity it represents, employs, advises, or acts on behalf of.

All formal correspondence relating to the Work — including requests for permissions outside the scope of the license, commercial licensing inquiries, notices of alleged infringement, academic correspondence, and any other matter requiring response from Category One Limited or the author — should be directed as follows:

Permissions: permissions@geno.ac
Legal and licensing: legal@geno.ac
Infringement notices: dmca@geno.ac

Substantive legal positions and licensing decisions are made by Category One Limited and, where moral rights are at issue, by the author.